Both in Pharmaceuticals
ALX Oncology Holdings vs Entrada Therapeutics
Over the past year ALXO returned −6.8% and TRDA returned −23.6%; their daily moves had a correlation of 0.26.
ALXO −6.8% TRDA −23.6%Growth of $1, one year, split-adjusted
| Metric | ALXO | TRDA |
|---|---|---|
| Price | $1.36 | $5.06 |
| Market cap | $188.1M | $197.0M |
| Today | +5.43% | +7.20% |
| 1 month | +22.5% | −6.6% |
| 6 months | −34.9% | −68.4% |
| Year to date | +20.4% | −50.8% |
| 1 year | −13.4% | −25.4% |
| Revenue growth (YoY) | — | −53.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −4762.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 42.0× |
| Net cash | $128.5M | $223.0M |
| Dividend yield | — | — |
| Volatility (60d) | 93.1% | 86.2% |
| Short % of float | 6.5% | 13.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).